330 related articles for article (PubMed ID: 37190064)
21. Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response.
Hii CS; Anson DS; Costabile M; Mukaro V; Dunning K; Ferrante A
J Biol Chem; 2004 Nov; 279(48):49825-34. PubMed ID: 15381709
[TBL] [Abstract][Full Text] [Related]
22. ERK5 activation is essential for osteoclast differentiation.
Amano S; Chang YT; Fukui Y
PLoS One; 2015; 10(4):e0125054. PubMed ID: 25885811
[TBL] [Abstract][Full Text] [Related]
23. Glucose-induced endothelin-1 expression is regulated by ERK5 in the endothelial cells and retina of diabetic rats.
Wu Y; Feng B; Chen S; Zuo Y; Chakrabarti S
Can J Physiol Pharmacol; 2010 Jun; 88(6):607-15. PubMed ID: 20628425
[TBL] [Abstract][Full Text] [Related]
24. The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
Tusa I; Gagliardi S; Tubita A; Pandolfi S; Menconi A; Lulli M; Dello Sbarba P; Stecca B; Rovida E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681917
[TBL] [Abstract][Full Text] [Related]
25. ERK5 signalling in prostate cancer promotes an invasive phenotype.
Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY
Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977
[TBL] [Abstract][Full Text] [Related]
26. Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.
Pereira DM; Rodrigues CMP
Trends Mol Med; 2020 Apr; 26(4):394-407. PubMed ID: 32277933
[TBL] [Abstract][Full Text] [Related]
27. Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway.
Benito-Jardón L; Díaz-Martínez M; Arellano-Sánchez N; Vaquero-Morales P; Esparís-Ogando A; Teixidó J
Cancer Res; 2019 May; 79(9):2244-2256. PubMed ID: 30833419
[TBL] [Abstract][Full Text] [Related]
28. Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease.
Sato Y; Harada K; Kizawa K; Sanzen T; Furubo S; Yasoshima M; Ozaki S; Ishibashi M; Nakanuma Y
Am J Pathol; 2005 Jan; 166(1):49-60. PubMed ID: 15631999
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
[TBL] [Abstract][Full Text] [Related]
30. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival.
Jacque E; Schweighoffer E; Tybulewicz VL; Ley SC
J Exp Med; 2015 Jun; 212(6):883-92. PubMed ID: 25987726
[TBL] [Abstract][Full Text] [Related]
31. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway.
Wang X; Merritt AJ; Seyfried J; Guo C; Papadakis ES; Finegan KG; Kayahara M; Dixon J; Boot-Handford RP; Cartwright EJ; Mayer U; Tournier C
Mol Cell Biol; 2005 Jan; 25(1):336-45. PubMed ID: 15601854
[TBL] [Abstract][Full Text] [Related]
32. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.
Sohn SJ; Lewis GM; Winoto A
EMBO J; 2008 Jul; 27(13):1896-906. PubMed ID: 18548009
[TBL] [Abstract][Full Text] [Related]
33. G alpha(q) acts as an adaptor protein in protein kinase C zeta (PKCzeta)-mediated ERK5 activation by G protein-coupled receptors (GPCR).
García-Hoz C; Sánchez-Fernández G; Díaz-Meco MT; Moscat J; Mayor F; Ribas C
J Biol Chem; 2010 Apr; 285(18):13480-9. PubMed ID: 20200162
[TBL] [Abstract][Full Text] [Related]
34. MEK5/ERK5 pathway: the first fifteen years.
Drew BA; Burow ME; Beckman BS
Biochim Biophys Acta; 2012 Jan; 1825(1):37-48. PubMed ID: 22020294
[TBL] [Abstract][Full Text] [Related]
35. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
[TBL] [Abstract][Full Text] [Related]
36. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
[TBL] [Abstract][Full Text] [Related]
37. Activation of extracellular signal-regulated protein kinase 5 downregulates FasL upon osmotic stress.
Wang X; Finegan KG; Robinson AC; Knowles L; Khosravi-Far R; Hinchliffe KA; Boot-Handford RP; Tournier C
Cell Death Differ; 2006 Dec; 13(12):2099-108. PubMed ID: 16710360
[TBL] [Abstract][Full Text] [Related]
38. ERK5 and its role in tumour development.
Lochhead PA; Gilley R; Cook SJ
Biochem Soc Trans; 2012 Feb; 40(1):251-6. PubMed ID: 22260700
[TBL] [Abstract][Full Text] [Related]
39. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
40. Multisite phosphorylation of Erk5 in mitosis.
Díaz-Rodríguez E; Pandiella A
J Cell Sci; 2010 Sep; 123(Pt 18):3146-56. PubMed ID: 20736311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
